Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Beginning Cash Balance: 2013-2025

Historic Beginning Cash Balance for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Sep 2025 value amounting to $187.7 million.

  • Amphastar Pharmaceuticals' Beginning Cash Balance fell 1.02% to $187.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $192.1 million, marking a year-over-year decrease of 29.06%. This contributed to the annual value of $144.3 million for FY2024, which is 7.56% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Beginning Cash Balance stood at $187.7 million for Q3 2025, which was up 2.68% from $182.8 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Beginning Cash Balance ranged from a high of $270.8 million in Q4 2023 and a low of $82.7 million during Q2 2021.
  • In the last 3 years, Amphastar Pharmaceuticals' Beginning Cash Balance had a median value of $182.8 million in 2025 and averaged $181.6 million.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Beginning Cash Balance skyrocketed by 108.80% in 2022 and then decreased by 29.06% in 2024.
  • Quarterly analysis of 5 years shows Amphastar Pharmaceuticals' Beginning Cash Balance stood at $106.6 million in 2021, then soared by 47.49% to $157.2 million in 2022, then soared by 72.22% to $270.8 million in 2023, then dropped by 29.06% to $192.1 million in 2024, then dropped by 1.02% to $187.7 million in 2025.
  • Its Beginning Cash Balance was $187.7 million in Q3 2025, compared to $182.8 million in Q2 2025 and $151.6 million in Q1 2025.